Breakfast Satellite Sessions
| HCV Elimination by 2026: Australia Leads the World |
 |
Symposium Objectives:
Australia has arguably one of the best systems in the world for accessing Direct Acting Antiviral HCV treatment for patients living with chronic Hepatitis C Virus. Dr Norman Swan leads a panel of national experts in a Q&A-style discussion to determine how Australia will now lead the world in the eradication of HCV.
Australia has arguably one of the best systems in the world for accessing Direct Acting Antiviral HCV treatment for patients living with chronic Hepatitis C Virus. Dr Norman Swan leads a panel of national experts in a Q&A-style discussion to determine how Australia will now lead the world in the eradication of HCV.
| Date: | Friday 30 September 2016 |
| Location: | Gold Coast Convention Centre |
| 7.00am: | Registration & Breakfast |
| 7.30am: | HCV Eradication by 2025. Australia Will Lead the World |
| 8.45am: | Close |
| Cost: | Complimentary - Breakfast, tea & coffee will be provided |
| Registration: | Register through the online conference registration system or contact the secretariat at info@hepatitis.org.au to include to your registration. |
Facilitator:
- Dr Norman Swan (ABC Health Report)
- Mr Brent Allan (Living Positive Victoria, Melbourne)
- Mrs Joanne Morgan (Australian Hepatology Association & Royal Adelaide Hospital, Adelaide)
- Adjunct Associate Professor Levinia Crooks AM (Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine)
- Dr Mark O’Reilly (Prahran Market Clinic, Melbourne)
- Professor Greg Dore (Kirby Institute & St Vincent’s Hospital, Sydney)
- Professor Alex Thompson (Australian Liver Association & St Vincent’s Hospital, Melbourne)
- Professor Andrew Lloyd (Kirby Institute, Prince of Wales Hospital, and Justice Health & Forensic Mental Health Network, New South Wales)
- Ms Helen Tyrell (Hepatitis Australia, Canberra)
| Curing HCV - Leave no Patient Behind |
 |
| Date: | Saturday 1 October 2016 |
| Time: | 7.30am - 9.15am |
| Location: | Gold Coast Convention & Exhibition Centre |
| Cost: | Complimentary - Breakfast, tea & coffee will be provided |
| Registration: | Register through the online conference registration system or contact the secretariat at info@hepatitis.org.au to include to your registration. |
Whilst the new all-oral direct acting antivirals have revolutionised the treatment of hepatitis C in Australia, challenges persist with certain patient types and non-traditional treatment settings. The AbbVie Satellite Symposium will address some of these challenges through real world case studies presented by a panel of local experts. This interactive session will provide an overview of the tools, data and resources available to inform clinical decisions, as well as other considerations in these complex patients and diverse environments. Delegates will have the opportunity to share their own clinical decisions through live polling.
- Introduction - A/Prof Simone Strasser, Royal Prince Alfred Hospital
- Curing the Co-infected in the Community - Dr Phillip Read, Kirketon Road Centre
- Taking Treatment to the Patient – Beyond traditional settings - Jana Van der Jagt, Port Macquarie Hospital
- The Legacy of Resistance Associated Substitutions - Prof Alex Thompson, St Vincent’s Hospital Melbourne
